COVID-19 could worsen cerebral amyloid angiopathy.

Dewisme J, Lebouvier T, Vannod-Michel Q, Lille COVID Research Network (LICORNE), Prevot V, Maurage CA

Open source

DOI
10.1093/jnen/nlad049
Published
2023 Aug 21
Container
Journal of neuropathology and experimental neurology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jnen/nlad049,
  title = {COVID-19 could worsen cerebral amyloid angiopathy.},
  author = {Dewisme J and Lebouvier T and Vannod-Michel Q and Lille COVID Research Network (LICORNE) and Prevot V and Maurage CA},
  year = {2023},
  journal = {Journal of neuropathology and experimental neurology},
  doi = {10.1093/jnen/nlad049},
  url = {https://doi.org/10.1093/jnen/nlad049}
}

RIS

TY  - JOUR
TI  - COVID-19 could worsen cerebral amyloid angiopathy.
AU  - Dewisme J
AU  - Lebouvier T
AU  - Vannod-Michel Q
AU  - Lille COVID Research Network (LICORNE)
AU  - Prevot V
AU  - Maurage CA
PY  - 2023
JO  - Journal of neuropathology and experimental neurology
DO  - 10.1093/jnen/nlad049
UR  - https://doi.org/10.1093/jnen/nlad049
ER  - 

APA

J, D., T, L., Q, V., (LICORNE), L. C. R. N., V, P., & CA, M. (2023). COVID-19 could worsen cerebral amyloid angiopathy.. Journal of neuropathology and experimental neurology. https://doi.org/10.1093/jnen/nlad049

Source records